Rodolfo J. Galindo

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

W. Timothy Garvey, Juan P. Frías, Ania M. Jastreboff et al. · The Lancet · 2023 · 590 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +6

American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update

Lawrence Blonde, Guillermo E. Umpierrez, Sarah Reddy et al. · Endocrine Practice · 2022 · 431 citations · Full text

Diabetes Management, Health Policy, American Association +6

American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update

Susan L. Samson, Priyathama Vellanki, Lawrence Blonde et al. · Endocrine Practice · 2023 · 330 citations

Diabetes Management, Comprehensive Type 2, Health Policy +5

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

David C. Klonoff, Jing Wang, David Rodbard et al. · Journal of Diabetes Science and Technology · 2022 · 254 citations · Full text

Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study

Francisco J. Pasquel, Katerina Tsegka, Heqiong Wang et al. · Diabetes Care · 2019 · 153 citations · Full text